Patents
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
09/2010
09/01/2010CN101817780A Preparation method of pyridine-2-formaldehyde
08/2010
08/31/2010US7786328 e.g. benzoic acid 2-[4-dimethylamino-4-(3-methyl-benzyl)-cyclohexylcarbamoyl]-benzyl ester; noradrenaline and serotonin reuptake ihibitor; opioid ORL-1 receptor ligand; analgesic, antidepressant, anxiolytic agent, neurodegenerative diseases
08/31/2010US7786316 Metalloprotein inhibitors
08/31/2010US7786305 Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity
08/31/2010US7786177 Phenylalanine enamide derivatives
08/31/2010US7786165 Antidiabetic agents; obesity; insulin resistance; neurodegenerative diseases; Alzheimer's disease
08/31/2010US7786147 used for the treatment of Parkinson's disease, Huntington disease, Alzheimer's disease, amyotrophic lateral sclerosis, spinal muscular atrophy, ataxia, Pick's disease, Pick's disease, vision defects, Cruetzfelt-Jacob syndrome or Alzheimer's disease
08/31/2010US7786122 use to treat Alzheimer's Disease; (2R)-2-[N-(4-Chlorobenzenesulfonyl)-N-(4-methoxybenzyl)amino]-4-methylpentanoic acid amide for example
08/31/2010US7786121 such as 6-(4-ethoxy-phenyl)-2S-hydroxy-3R-[4-(3-methoxy-phenyl)-piperazine-1-carbonyl]-hexanoic acid hydroxyamide, used for the treatment or prophylaxis of arthritis in mammals
08/31/2010US7786044 e.g.4-Amino-6-(4-chlorophenyl)-5-fluoro-3-vinylpyridine-2-carboxylic acid; 4-Acetylamino-6-(4-chloro-2-fluoro-3-methoxyphenyl)-3-trimethylsilanylethynylpyridine-2-carboxylic acid methyl ester;
08/31/2010US7786043 e.g.2-(5-chloro-6-phenylpyridin-2-yl)-5,6,7,8-tetrahydroquinazoline; 4-[3-methyl-6-(5,6,7,8-tetrahydroquinazolin-2-yl)pyridin-2-yl]benzonitrile
08/31/2010US7785678 positive dielectric anisotropy; electrooptics; chemical, electrical resistance
08/31/2010CA2574600C Pyridine derivatives
08/31/2010CA2549558C Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
08/26/2010WO2010096722A1 3-oxo-2, 3-dihydro- [1,2, 4] triazolo [4, 3-a]pyridines as soluble epoxide hydrolase (seh) inhibitors
08/26/2010WO2010094659A1 Amine or amino alcohols as glyt1 inhibitors
08/26/2010WO2010094644A1 Substituted pyridine derivatives and their medical use
08/26/2010WO2010094169A1 Magnesium-cobalt based catalyst for synthesizing pyridine base from formaldehyde, acetaldehyde and ammonia and preparation method thereof
08/26/2010WO2010094168A1 Ti-containing catalyst for synthesizing pyridine bases by reacting ammonia, formaldehyde and acetaldehyde and its preparation method
08/26/2010WO2010076033A9 Toluidine sulfonamides and their use
08/26/2010WO2010066682A4 Compounds, pharmaceutical composition and methods for use in treating metabolic disorders
08/26/2010WO2010019701A3 Diaryl urea derivatives
08/26/2010WO2010003614A3 Transfection solution
08/26/2010US20100217006 Inhibitor Of Ischemic Disorders
08/26/2010US20100216849 Biphenylcarboxamides
08/26/2010US20100216818 Inhibitors of Post-Amadori Advanced Glycation End Products
08/26/2010US20100216758 Pyridone Compounds
08/26/2010US20100216638 Herbicidally active bicyclic 1,3-dione compounds
08/26/2010US20100216252 use of the complexes obtained as fluorescent markers, and as relaxation agents for NMR or for NMR imaging
08/26/2010US20100215661 Nicotinamide derivates useful as p38 inhibitors
08/26/2010US20100215652 Nicotinamide derivates useful as p38 inhibitors
08/26/2010US20100215574 Process for producing an injectable medicament preparation
08/26/2010US20100213826 Material for organic photoelectric device, and organic photoelectric device thereby
08/26/2010CA2752807A1 Amine or amino alcohols as glyt1 inhibitors
08/25/2010EP2220045A1 Substituted pyridyl amide compounds as modulators of the histamine h3 receptor
08/25/2010EP2220044A1 P38 map kinase inhibitors
08/25/2010EP2220043A1 Crystalline form of an antimalarial compound
08/25/2010EP2220042A1 Novel bifunctional compounds which inhibit protein kinases and histone deacetylases
08/25/2010EP2220030A2 4- (p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases
08/25/2010EP2220029A1 Novel compounds
08/25/2010EP2069302B1 Substituted pyridylmethyl bicyclocarboxyamide compounds
08/25/2010EP1366016B1 Process for the preparation of arylethanoldiamines useful as agonists of the beta-3-adrenoceptor
08/25/2010CN1997619B Phenyl derivatives comprising an acetylene group
08/25/2010CN101812699A Method for simultaneously preparing tetrachloropyridine and diglycolic acid in cathode and anode chambers
08/25/2010CN101812093A One-dimensional micron or submicron material of polypyridine platinum complex as well as preparation method and application thereof
08/25/2010CN101812084A Rare earth metal amine compound containing aromatic amine methylene pyrrole ligand, preparation method and application thereof
08/25/2010CN101812016A Method for preparing 6-methylnicotinic acid etoricoxib intermediate and ester thereof
08/25/2010CN101812015A Preparation method of flupirtine
08/25/2010CN101402600B Process for producing vitamin B6
08/25/2010CN101302188B Bidentate ligand 4,4'- bis (hydroxymethyl)-2,2'dipyridine, preparation thereof and application to polyketone synthesis
08/25/2010CN101157652B Antitumor activity bipyridine methyl amine compound and preparation method thereof
08/24/2010US7781960 Metal complex compound and organic electroluminescent element using the same
08/24/2010US7781628 in which an organic thin film layer comprising a single layer or plural layers including at least a light emitting layer is sandwiched between a cathode and an anode; high luminous efficiency
08/24/2010US7781593 CB1 cannabinoid receptor antagonists/inverse agonists; 5-(4-chloro-phenyl)-N-((1R,2R)-2-hydroxy-cyclohexyl)-6-(3-methoxy-propyl)-nicotinamide for example; eating disorders, obesity, diabetes type II or non insulin dependent diabetes (NIDD), neuroinflammation, diarrhea, drug abuse
08/24/2010US7781592 Thione derivative, method for the preparation thereof, and pharmaceutical composition containing the same
08/24/2010US7781470 Aminodicarboxylic acid derivatives having pharmaceutical properties
08/24/2010US7781461 Neuropeptide Y receptor antagonists comprising 4-(tert-butylsulfonylamino)-N-[5-(trifluoromethyl)pyridin-2-yl]cyclohexane-1-carboxamide and a pharmaceutically acceptable carrier, used for the treatment of obesity and as anorexigenic agents
08/24/2010US7781458 Derivatives of pyridine and quinoline
08/24/2010US7781454 Substituted indazoles, benzotriazoles, and related bicyclic compounds; HIV (human immunodeficiency virus) reverse transcriptase inhibitors; delays onset of AIDS or AIDS related complex
08/24/2010CA2423103C N-acylsulfonamide apoptosis promoters
08/19/2010WO2010093890A2 Processes for producing phenyl-6-(1-(phenyl)ureido)nicotinamides)
08/19/2010WO2010093889A2 Solid forms of 2-(2, 4-difluorophenyl)-6-(1-(2,6-difluorophenyl)ureido)nicotinamide
08/19/2010WO2010093849A2 Phenylalanine amide derivatives useful for treating insulin-related diseases and conditions
08/19/2010WO2010093595A1 Fungicidal 2-pyridones
08/19/2010WO2010092180A1 Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy
08/19/2010WO2010092043A1 Phenoxy acetic acid derivatives
08/19/2010WO2010075280A3 Coumarin-based compounds for the treatment of alzheimer's disease and cancer
08/19/2010WO2010057922A4 Curable composition comprising a thermolatent base
08/19/2010WO2010047774A3 Inhibitors of mycobacterium tuberculosis malate synthase, methods of marking and uses thereof
08/19/2010US20100210837 Pactamycin biosynthetic gene cluster
08/19/2010US20100210694 New no-donor aspirin derivatives
08/19/2010US20100210693 Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease
08/19/2010US20100210653 Novel Compounds, Their Preparations and Use
08/19/2010US20100210603 Novel sulfonamide inhibitors of aspartyl protease
08/19/2010US20100210593 Pyridine- and Pyrimidinecarboxamides as CXCR2 Modulators
08/19/2010DE102009055319A1 Kristalline Formen von [2-Amion-6-(4-fluoro-benzylamino)-pyridin-3-yl]-carbamidsäure-ethylester Crystalline forms of [2-Amion-6- (4-fluoro-benzylamino) -pyridin-3-yl] -carbamic acid ethyl ester
08/19/2010CA2752544A1 Solid forms of 2-(2, 4-difluorophenyl)-6-(1-(2,6-difluorophenyl)ureido)nicotinamide
08/19/2010CA2752190A1 Small molecule bradykinin b1 receptor antagonists
08/19/2010CA2751260A1 Phenoxy acetic acid derivatives
08/19/2010CA2750793A1 Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy
08/18/2010EP2218711A1 Oxime ether derivative and bactericide for agricultural and horticultural use
08/18/2010EP2217571A2 Novel precursors
08/18/2010EP2217570A2 Synthesis of diaminodinitropyridine and diaminodinitrobenzene
08/18/2010EP2217566A1 Bis-(sulfonylamino) derivatives in therapy 066
08/18/2010EP2217565A1 Compounds which modulate the cb2 receptor
08/18/2010EP2217229A1 Pharmaceutical compositions for modulating a kinase cascade and methods of use thereof
08/18/2010EP1940786B1 Biphenyl derivatives and their use in treating hepatitis c
08/18/2010EP1692109B1 Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs
08/18/2010EP0956865B2 MEDICINES COMPRISING Rho KINASE INHIBITOR
08/18/2010CN101809014A Method for producing pyrazol-3-yl-benzamide derivative
08/18/2010CN101808996A Nicotinamide derivatives, preparation thereof and therapeutic use thereof
08/18/2010CN101808995A Novel glucokinase activators and methods of using same
08/18/2010CN101808994A Compounds and methods for kinase modulation, and indications therefor
08/18/2010CN101808993A biocidal mixtures
08/18/2010CN101808992A 1,1,1-trifluoro-2-hydroxy-3-phenylpropane derivatives
08/18/2010CN101808986A Imidate compound and use thereof for pest control
08/18/2010CN101805326A 1,3-diaryl-3-aromatic amino-1-propanol compound and preparation method and application thereof
08/18/2010CN101805309A Benzamide derivatives useful as histone deacetylase inhibitors
08/18/2010CN101805286A Method for synthesizing midbody sulfamide of nicosulfuron
08/18/2010CN101805285A Nicotinic acid-contained curcumin ester derivative and preparation method and application thereof